Tier 2 · Liquid 3000

Starling Oncology, Inc.

STLN · Nasdaq · Healthcare. Identity, market observation, SEC facts, and source links remain separate and inspectable.

Price
$6.13
+0.00%
Coverage
Tier 2
Tier 2 · Liquid 3000
SEC CIK
0001799191
Liquidity rank
#2699
Observed dollar volume

SEC XBRL facts

FieldValuePeriod endFiling
Annual revenue$502.73M2025-12-310001799191-26-000007
Annual diluted EPS-0.542025-12-310001799191-26-000007
Quarterly revenue$161.28M2026-06-300001799191-26-000017
Quarterly diluted EPS-0.082026-06-300001799191-26-000017

SEC EDGAR Frames batch generated 2026-08-24T22:57:10.564Z. Frames are calendar-aligned and may not cover every filer or fiscal period.

Dividends

Trailing 12 months
Not published
Latest payment
Not published

Yahoo Finance corporate actions. Window: 2025-08-25 through 2026-08-25.

Seasonality

MonthMean returnPositiven

Monthly close-to-close returns, trailing 15 years where Yahoo history is available.

Sector news

No matching sector headlines were returned in the 72-hour window.

Filings and machine access

Latest SEC filingsSEC company browse
SEC submissions JSONDirect upstream record
Per-symbol JSONSame-origin machine contract

Context paths

HealthcareNasdaqBMY · Tier 1 peerDHR · Tier 1 peerISRG · Tier 1 peerPFE · Tier 1 peer

Provenance

IdentitySEC company tickers and Nasdaq Symbol Directory
Quote and corporate actionsYahoo Finance chart
FundamentalsSEC EDGAR Frames